PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. chiasiang_93@hotmail.com.\', \'School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia. chiasiang_93@hotmail.com.\', \'School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.\', \'School of Applied Sciences, University of Huddersfield, Huddersfield, UK.\', \'School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10787-021-00915-7
?:hasPublicationType
?:journal
  • Inflammopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 35099680
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.925
?:rankingScore_hIndex
  • 41
?:title
  • The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35099680>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35099680>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all